TJ Cradick, Chief Scientific Officer at Excision Bio, discusses their CRISPR HIV therapy that recently proceeded into clinical trials in this episode and their ongoing work on other viral diseases.
Want to check another podcast?
Enter the RSS feed of a podcast, and see all of their public statistics.
